Cerebral toxoplasmosis in HIV-infected patients: a review.
Dian S, Ganiem AR, Ekawardhani S.
Pathog Glob Health. 2023 Feb;117(1):14-23. doi: 10.1080/20477724.2022.2083977. Epub 2022 Jun 11.
HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment.
Bowen LN, Smith B, Reich D, Quezado M, Nath A.
Nat Rev Neurol. 2016 Oct 27;12(11):662-674. doi: 10.1038/nrneurol.2016.149.
HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease.
Vidal JE.
J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219867315. doi: 10.1177/2325958219867315.
[Toxoplasma encephalitis].
Yamamoto T.
Nihon Naika Gakkai Zasshi. 2006 Jul 10;95(7):1260-2. doi: 10.2169/naika.95.1260.
Toxoplasma meningoencephalitis in HIV-seronegative patients: clinical patterns, imaging features and treatment outcome.
Pradhan S, Yadav R, Mishra VN.
Trans R Soc Trop Med Hyg. 2007 Jan;101(1):25-33. doi: 10.1016/j.trstmh.2006.02.021. Epub 2006 Sep 28.
Toxoplasmosis.
Lynfield R, Guerina NG.
Pediatr Rev. 1997 Mar;18(3):75-83. doi: 10.1542/pir.18-3-75.
[Cerebral toxoplasmosis].
Ribera Pascuet E, López Aldeguer J, Pérez Elías MJ, Podzamczer Palter D.
Enferm Infecc Microbiol Clin. 1998;16 Suppl 1:45-51.
Toxoplasma gondii meningoencephalitis without cerebral MRI findings in a patient with ulcerative colitis under immunosuppressive treatment.
Assimakopoulos SF, Stamouli V, Dimitropoulou D, Spiliopoulou A, Panos G, Anastassiou ED, Marangos M, Spiliopoulou I.
Infection. 2015 Oct;43(5):589-93. doi: 10.1007/s15010-015-0730-9. Epub 2015 Jan 27.
Cerebral toxoplasmosis in the twenty-first century.
van Deuzen CM, Rijnders BJA, Bax HI, Rokx C, de Vries-Sluijs TEMS, Schurink CAM, Nouwen JL, de Mendonça-Melo M, Anas AA, van Gorp ECM, Slobbe L, van Hellemond JJ, van Nood E.
AIDS. 2026 Feb 1;40(2):143-150. doi: 10.1097/QAD.0000000000004356. Epub 2025 Sep 24.
Immunopathogenesis of cerebral toxoplasmosis.
Suzuki Y.
J Infect Dis. 2002 Dec 1;186 Suppl 2:S234-40. doi: 10.1086/344276.
